solid tumor

a lot of scissors
Biotech

Takeda shoots down bispecifics bagged in Maverick buyout

The two bispecific terminations, coupled to the removal of a third asset, halved the number of cancer candidates in Takeda’s phase 1 and 2 pipeline.
Nick Paul Taylor May 8, 2025 8:30am
Blue race track

Relay starts 3rd layoff wave in one year, shedding 70 staffers

Apr 4, 2025 11:30am
Sketch of lungs

BioNTech posts survival data behind bispecific's phase 3 push

Mar 28, 2025 8:00am
Glowing puzzle piece fitting into puzzle

Servier pays $70M for Black Diamond's deprioritized cancer drug

Mar 19, 2025 7:53am
Three blocks displaying from left to right a person a handshake and another person

Nanobiotix tweaks J&J deal for cancer drug to conserve cash

Mar 18, 2025 5:23am
chop down cut tree chainsaw ax

Amgen, CytomX ax T-cell engager after assessing data, priorities

Mar 7, 2025 5:39am